Observational studyJAMA cardiology2020

Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs.

Aylin Ornelas-Loredo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.